
Alibaba Health Information Technology Limited
ALBBY | OTC
$7.35
+$0.24 (+3.38%)
At close: Oct 30, 2026, 3:58 PM ET
$7.35
$0.00 (-0.06%)
After-hours:
Oct 30, 2026, 5:00 PM ET
Fiscal Year Period Ending | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
Revenue | 34.26B | 30.6B | 27.03B | 26.76B | 20.58B | 15.52B |
Cost of Revenue | 26.05B | 23.17B | 21.13B | 21.06B | 16.47B | 11.9B |
Gross Profit | 8.21B | 7.43B | 5.9B | 5.7B | 4.11B | 3.62B |
Operating Income | 1.84B | 1.58B | 717.4M | -31.79M | -1.1B | 58.56M |
Interest Income | 447.15M | 464.85M | 478.03M | 331.59M | 209.76M | 164.33M |
Pretax Income | 2.27B | 1.56B | 939.4M | 550.99M | -252.51M | 401.22M |
Net Income | 1.94B | 1.43B | 883.48M | 535.65M | -265.56M | 348.59M |
Selling & General & Admin | 2.83B | 2.65B | 2.14B | 2.15B | 2.38B | 1.52B |
Research & Development | 788.35M | 720.05M | 705.38M | 677.82M | 728.83M | 423.63M |
Other Expenses | 2.76B | 2.49B | 2.34B | 2.82B | 2.02B | 1.57B |
Operating Expenses | 6.37B | 5.86B | 5.18B | 5.65B | 5.13B | 3.51B |
Interest Expense | 1.35M | 2.61M | 5.97M | 5.83M | 3.82M | n/a |
Selling & Marketing Expenses | 2.45B | 2.26B | 1.78B | 1.77B | 1.98B | 1.22B |
Cost & Expenses | 32.42B | 29.02B | 26.31B | 26.71B | 21.6B | 15.41B |
Income Tax Expense | 337.88M | 127.95M | 56.26M | 14.49M | 13.43M | 58.54M |
Shares Outstanding (Basic) | 16.2B | 16.07B | 14.09B | 13.5B | 13.48B | 13.25B |
Shares Outstanding (Diluted) | 16.2B | 16.14B | 14.09B | 13.54B | 13.48B | 13.33B |
EPS (Basic) | 0.12 | 0.09 | 0.06 | 0.04 | -0.02 | 0.03 |
EPS (Diluted) | 0.12 | 0.09 | 0.06 | 0.04 | -0.02 | 0.03 |
EBITDA | 1.47B | 1.62B | 999.05M | 12.22M | -188.12M | 77.1M |
EBIT | 1.41B | 1.56B | 945.37M | -51.5M | -248.7M | 37.47M |
Depreciation & Amortization | 53.23M | 57.61M | 53.68M | 63.72M | 60.58M | 39.63M |
Add to Watchlist
Select watchlists to add or remove ALBBY